First Time Loading...

Cortexyme Inc
NASDAQ:CRTX

Watchlist Manager
Cortexyme Inc Logo
Cortexyme Inc
NASDAQ:CRTX
Watchlist
Price: 1.33 USD -5% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

CRTX price has not been updated for more than 4 months. This may indicate that the stock has been delisted.
CRTX's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Cortexyme, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. [ Read More ]

The intrinsic value of one CRTX stock under the Base Case scenario is 2.59 USD. Compared to the current market price of 1.33 USD, Cortexyme Inc is Undervalued by 49%.

Key Points:
CRTX Intrinsic Value
Base Case
2.59 USD
Undervaluation 49%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Cortexyme Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CRTX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Cortexyme Inc

Provide an overview of the primary business activities
of Cortexyme Inc.

What unique competitive advantages
does Cortexyme Inc hold over its rivals?

What risks and challenges
does Cortexyme Inc face in the near future?

Has there been any significant insider trading activity
in Cortexyme Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cortexyme Inc.

Provide P/S
for Cortexyme Inc.

Provide P/E
for Cortexyme Inc.

Provide P/OCF
for Cortexyme Inc.

Provide P/FCFE
for Cortexyme Inc.

Provide P/B
for Cortexyme Inc.

Provide EV/S
for Cortexyme Inc.

Provide EV/GP
for Cortexyme Inc.

Provide EV/EBITDA
for Cortexyme Inc.

Provide EV/EBIT
for Cortexyme Inc.

Provide EV/OCF
for Cortexyme Inc.

Provide EV/FCFF
for Cortexyme Inc.

Provide EV/IC
for Cortexyme Inc.

Show me price targets
for Cortexyme Inc made by professional analysts.

What are the Revenue projections
for Cortexyme Inc?

How accurate were the past Revenue estimates
for Cortexyme Inc?

What are the Net Income projections
for Cortexyme Inc?

How accurate were the past Net Income estimates
for Cortexyme Inc?

What are the EPS projections
for Cortexyme Inc?

How accurate were the past EPS estimates
for Cortexyme Inc?

What are the EBIT projections
for Cortexyme Inc?

How accurate were the past EBIT estimates
for Cortexyme Inc?

Compare the revenue forecasts
for Cortexyme Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cortexyme Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cortexyme Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cortexyme Inc compared to its peers.

Compare the P/E ratios
of Cortexyme Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Cortexyme Inc with its peers.

Analyze the financial leverage
of Cortexyme Inc compared to its main competitors.

Show all profitability ratios
for Cortexyme Inc.

Provide ROE
for Cortexyme Inc.

Provide ROA
for Cortexyme Inc.

Provide ROIC
for Cortexyme Inc.

Provide ROCE
for Cortexyme Inc.

Provide Gross Margin
for Cortexyme Inc.

Provide Operating Margin
for Cortexyme Inc.

Provide Net Margin
for Cortexyme Inc.

Provide FCF Margin
for Cortexyme Inc.

Show all solvency ratios
for Cortexyme Inc.

Provide D/E Ratio
for Cortexyme Inc.

Provide D/A Ratio
for Cortexyme Inc.

Provide Interest Coverage Ratio
for Cortexyme Inc.

Provide Altman Z-Score Ratio
for Cortexyme Inc.

Provide Quick Ratio
for Cortexyme Inc.

Provide Current Ratio
for Cortexyme Inc.

Provide Cash Ratio
for Cortexyme Inc.

What is the historical Revenue growth
over the last 5 years for Cortexyme Inc?

What is the historical Net Income growth
over the last 5 years for Cortexyme Inc?

What is the current Free Cash Flow
of Cortexyme Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cortexyme Inc.

Financials

Balance Sheet Decomposition
Cortexyme Inc

Current Assets 93.7m
Cash & Short-Term Investments 90.2m
Other Current Assets 3.6m
Non-Current Assets 10.2m
Long-Term Investments 3.6m
PP&E 684k
Intangibles 5.9m
Current Liabilities 3.1m
Accounts Payable 570k
Accrued Liabilities 2.4m
Other Current Liabilities 76k
Non-Current Liabilities 248k
Other Non-Current Liabilities 248k
Efficiency

Earnings Waterfall
Cortexyme Inc

Revenue
0 USD
Operating Expenses
-51.2m USD
Operating Income
-51.2m USD
Other Expenses
-470k USD
Net Income
-51.7m USD

Free Cash Flow Analysis
Cortexyme Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

CRTX Profitability Score
Profitability Due Diligence

Cortexyme Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

28/100
Profitability
Score

Cortexyme Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

CRTX Solvency Score
Solvency Due Diligence

Cortexyme Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
High Altman Z-Score
73/100
Solvency
Score

Cortexyme Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CRTX Price Targets Summary
Cortexyme Inc

There are no price targets for CRTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CRTX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CRTX Price
Cortexyme Inc

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-97%
5Y 5Y
-96%
10Y 10Y
-96%
Annual Price Range
1.33
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return 7.81%
Standard Deviation of Annual Returns 76.5%
Max Drawdown -99%
Shares Statistics
Market Capitalization 48.3m USD
Shares Outstanding 36 150 800
Percentage of Shares Shorted 14.39%

CRTX Return Decomposition
Main factors of price return

What is price return decomposition?

CRTX News

Last Important Events
Cortexyme Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Cortexyme Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Cortexyme Inc Logo
Cortexyme Inc

Country

United States of America

Industry

Biotechnology

Market Cap

48.3m USD

Dividend Yield

0%

Description

Cortexyme, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. The company is headquartered in South San Francisco, California and currently employs 55 full-time employees. The company went IPO on 2019-05-09. The firm provides 3CLpro inhibitor, COR803 product, is a lead compound for treatment of coronavirus infections. The Company’s products pipeline includes drug candidates for the treatment of central nervous system (CNS) disorders including Alzheimer’s disease; for the treatment of oncology applications including the prevention of oral squamous cell carcinoma, and for the treatment of underserved and chronic conditions such as periodontitis. The Company’s COR388 is for the treatment of Alzheimer’s disease and Parkinson's disease. The firm's COR588 is in Phase I clinical trial and targeting to use in the treatment of periodontal disease and other P. gingivalis-related indications. The firm is also developing COR588, is a second-generation brain penetrant lysine gingipain inhibitor.

Contact

CALIFORNIA
South San Francisco
269 E Grand Ave
+14159105717.0
https://www.cortexyme.com/

IPO

2019-05-09

Employees

55

Officers

Exec. VP of R&D
Dr. Leslie J. Holsinger Ph.D.
CEO & Director
Dr. Dirk Thye M.D.
VP of Fin., Principal Financial Officer & Chief Accounting Officer
Mr. Ted Monohon
Chief Bus. Officer
Mr. Brendan Hannah M.B.A.
Chief Medical Officer
Dr. Karen L. Smith L.L.M, L.L.M., M.B.A., M.D., PH.D.

See Also

Discover More
What is the Intrinsic Value of one CRTX stock?

The intrinsic value of one CRTX stock under the Base Case scenario is 2.59 USD.

Is CRTX stock undervalued or overvalued?

Compared to the current market price of 1.33 USD, Cortexyme Inc is Undervalued by 49%.